SNB-1 is a neuronal v-SNARE protein essential for synaptic vesicle fusion and neurotransmitter release . The SNB-1 antibody (designated SB1) was developed to study synaptic architecture and vesicle dynamics. It recognizes an epitope (PRPSNKRLQQ) within the N-terminal cytoplasmic domain (amino acids 1–86) of SNB-1 .
Immunogen: Mice were immunized with a His₆-tagged SNB-1 fusion protein lacking the transmembrane domain .
Hybridoma lines: Three IgG1 clones (2E6, 5D1, 5G1) were generated, with 5D1 (SB1) showing superior specificity and deposited in the Developmental Studies Hybridoma Bank (DSHB) .
Specificity:
SB1 enables visualization of synaptic vesicle distribution in GABAergic motor neurons. Key findings include:
Reduced anterograde vesicle flux in casy-1 mutants, rescued by CASY-1C overexpression .
Impaired vesicle mobility after unc-104 RNAi, highlighting UNC-104/KIF1A's role in transport .
Co-immunoprecipitation: SB1 confirmed SNB-1 interactions with UNC-10 (active zones) and SAD-1 kinase (neuronal polarity) .
Colocalization: SNB-1 puncta overlap with presynaptic markers like UNC-10 and SNT-1 .
| Parameter | SB1 Performance |
|---|---|
| Target Gene | snb-1 |
| Subcellular Localization | Synaptic vesicles |
| Western Blot | +++ (16 kDa band in WT) |
| Immunohistochemistry | +++ (nerve ring, cords) |
| Epitope | PRPSNKRLQQ (cytoplasmic) |
Neuronal Polarity: SNB-1 interacts with SAD-1 kinase and Neurabin (NAB-1) to restrict axonal fate .
Vesicle Transport: CASY-1 C-terminal recruits UNC-104/KIF1A to regulate GABAergic vesicle motility .
Synaptic Defects: snb-1 mutants show aberrant vesicle clustering and neurotransmitter release .
How is the SNB-1 antibody validated for synaptic vesicle localization studies in C. elegans?
Methodology:
Use immunofluorescence on whole-mount C. elegans preparations. Compare staining patterns in wild-type and snb-1(md247) mutants. A 16 kDa band (wild-type) shifting to 19 kDa in mutants confirms specificity via Western blot .
Include controls like pre-immune serum and secondary antibody-only samples to rule out nonspecific binding.
Key Data:
What experimental designs optimize SNB-1 antibody use in dual-labeling studies?
How do SNB-1 antibody-epitope interactions influence mechanistic studies of synaptic trafficking?
How to resolve contradictions in SNB-1 antibody reactivity across model systems?
What quantitative approaches improve SNB-1 antibody-based synaptic vesicle density measurements?
Advanced Imaging:
Apply Airyscan super-resolution microscopy to resolve clustered SNB-1 punctae (<200 nm spacing).
Use Fiji/ImageJ macros for automated puncta counting, normalized to axonal length (e.g., Puncta Analyzer plugin).
How does SNB-1 antibody performance compare to CRISPR-tagged endogenous SNB-1 reporters?